全文获取类型
收费全文 | 35067篇 |
免费 | 4096篇 |
国内免费 | 824篇 |
专业分类
耳鼻咽喉 | 225篇 |
儿科学 | 895篇 |
妇产科学 | 562篇 |
基础医学 | 4830篇 |
口腔科学 | 1605篇 |
临床医学 | 3506篇 |
内科学 | 5739篇 |
皮肤病学 | 517篇 |
神经病学 | 2954篇 |
特种医学 | 473篇 |
外国民族医学 | 1篇 |
外科学 | 2461篇 |
综合类 | 3406篇 |
现状与发展 | 5篇 |
预防医学 | 5473篇 |
眼科学 | 746篇 |
药学 | 3537篇 |
35篇 | |
中国医学 | 1383篇 |
肿瘤学 | 1634篇 |
出版年
2024年 | 44篇 |
2023年 | 835篇 |
2022年 | 868篇 |
2021年 | 1849篇 |
2020年 | 1800篇 |
2019年 | 1729篇 |
2018年 | 1631篇 |
2017年 | 1679篇 |
2016年 | 1657篇 |
2015年 | 1704篇 |
2014年 | 2377篇 |
2013年 | 3657篇 |
2012年 | 2008篇 |
2011年 | 2183篇 |
2010年 | 1748篇 |
2009年 | 1809篇 |
2008年 | 1796篇 |
2007年 | 1720篇 |
2006年 | 1412篇 |
2005年 | 1136篇 |
2004年 | 1018篇 |
2003年 | 806篇 |
2002年 | 690篇 |
2001年 | 538篇 |
2000年 | 446篇 |
1999年 | 385篇 |
1998年 | 324篇 |
1997年 | 243篇 |
1996年 | 226篇 |
1995年 | 238篇 |
1994年 | 169篇 |
1993年 | 187篇 |
1992年 | 144篇 |
1991年 | 119篇 |
1990年 | 87篇 |
1989年 | 95篇 |
1988年 | 92篇 |
1987年 | 62篇 |
1986年 | 52篇 |
1985年 | 88篇 |
1984年 | 71篇 |
1983年 | 49篇 |
1982年 | 38篇 |
1981年 | 44篇 |
1980年 | 32篇 |
1979年 | 28篇 |
1978年 | 22篇 |
1977年 | 13篇 |
1976年 | 14篇 |
1975年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
目的 了解芦山地震5年后雅安市高血压患者心理卫生问题检出率及其影响因素,为促进地震灾区高血压患者心理健康提供参考。方法 采用分层整群随机抽样方法,于2018年12月选取雅安市高血压患者800例作为研究对象。采用自编居民基本信息调查表收集患者的基本资料,采用12项一般健康问卷(GHQ-12)评定患者近期是否存在心理卫生问题,采用Logistic回归分析其影响因素。结果 回收有效问卷744份(93.00%),检出存在心理卫生问题者79例(10.62%)。单因素分析结果显示,不同婚姻状况(P?0.01)、家庭人均月收入(P=0.012)、是否接受社会救助(χ2=25.194,P?0.01)的高血压患者心理卫生问题检出率差异均有统计学意义。Logistic回归分析显示,未婚/分居/离异/丧偶(OR=3.879,P=0.015)以及接受社会救助(OR=4.705,P?0.01)是高血压患者存在心理卫生问题的危险因素。结论 雅安市高血压患者心理卫生问题检出率较低,未婚/分居/离异/丧偶者以及接受社会救助的高血压患者心理卫生问题可能更突出。 相似文献
3.
《Clinical oncology (Royal College of Radiologists (Great Britain))》2022,34(7):472-479
AimsTreatment decisions for older patients with breast cancer are complex and evidence is largely extrapolated from younger populations. Frailty and comorbidity need to be considered. We studied the baseline characteristics and treatment decisions in older patients in Christchurch with breast cancer and assessed survival outcomes and prognostic/discriminatory performance of several tools.Materials and methodsWe searched the Canterbury Breast Cancer Registry and identified patients aged 70 years or older at diagnosis with invasive, non-metastatic breast cancer between 1 June 2009 and 30 June 2015. We retrieved demographics, treatment and outcome information. Overall survival and breast cancer-specific survival were estimated. Tools analysing performance status and comorbidity were assessed for their prognostic and discriminatory power.ResultsIn total, 440 patients were identified. Primary surgery was carried out for 362 patients (82.3%): breast-conserving surgery in 114 (of whom 88.6% received radiation therapy); mastectomy in 248 (of whom 24.6% received radiation). Hormone therapy was given for 265 (71.1%) patients with oestrogen receptor-positive cancers. Two hundred and seventy-four (62.3%) patients received full standard treatment, which was associated with significantly improved 5-year survival and 5-year breast cancer-specific survival. The median estimated overall survival was 8.2 years (95% confidence interval 7.3–9.1 years). Of those who died, 71.3% of deaths were due to causes other than breast cancer or unknown causes. The comorbidity-adjusted life expectancy (CALE) showed partial prognostic accuracy. CALE, Charlson and Eastern Cooperative Oncology Group tools all showed discriminatory value.ConclusionIn this population-based series of older patients with breast cancer, showing high levels of primary and adjuvant treatment, patients were more likely to die of causes other than breast cancer. Performance status and comorbidity tools showed prognostic and discriminatory potential in this population supporting their use in treatment decision making. CALE showed the most potential to improve treatment decisions but requires validation in this population to improve prognostic accuracy. 相似文献
4.
5.
6.
7.
《Health & place》2022
Interventions that involve key aspects of community organizing, such as quantitative community assessments and organizational partnership support for the community, may promote residents' health. We evaluated the effectiveness of this form of intervention on mortality and its variability across individual-level household equivalized income tertiles, comparing 52,858 residents aged 65 and above in 12 intervention municipalities to 39,006 residents in nine control municipalities in Japan. During 1,166 days of follow-up, the adjusted hazard ratio for cumulative mortality among men in the intervention municipalities was 0.92 (95% confidence interval: 0.86, 0.99) compared to those in the control group, with similar results being observed across all income levels. Active utilization of data to evaluate communities and building intersectoral partnerships might lower older male residents’ mortality risk, regardless of their income status. 相似文献
8.
《The British journal of oral & maxillofacial surgery》2022,60(5):e677-e690
The naturally occurring cannabis plant has played an established role in pain management throughout recorded history. However, in recent years, both natural and synthetic cannabis-based products for medicinal use (CBPM) have gained increasing worldwide attention due to growing evidence supporting their use in alleviating chronic inflammatory and neuropathic pain associated with an array of conditions. In view of these products’ growing popularity in both the medical and commercial fields, we carried out a systematic review to ascertain the effects of cannabis and its synthetically derived products on orofacial pain and inflammation. The application of topical dermal cannabidiol formulation has shown positive findings such as reducing pain and improving muscle function in patients suffering from myofascial pain. Conversely, two orally-administered synthetic cannabinoid receptor agonists (AZD1940 and GW842166) failed to demonstrate significant analgesic effects following surgical third molar removal. There is a paucity of literature pertaining to the effects of cannabis-based products in the orofacial region; however, there is a wealth of high-quality evidence supporting their use for treating chronic nociceptive and neuropathic pain conditions in other areas. Further research is warranted to explore and substantiate the therapeutic role of CBPMs in the context of orofacial pain and inflammation. As evidence supporting their use expands, healthcare professionals should pay close attention to outcomes and changes to legislation that may impact and potentially benefit their patients. 相似文献
9.
10.